For decades, India has been a top player in global pharmaceuticals. But its drug regulatory system came under scrutiny after toxic chemicals were found in Indian-produced medicine that led to the deaths of scores of children in Gambia. Bloomberg reporter Zachary Mider and contributor Swati Gupta discuss their investigation into a pharmaceutical company and the ripple effects of its supply chain across the globe.
Read more: Poisoned Cough Syrup Killed Kids. Authorities Cut the Investigation Short
Listen to The Big Take podcast every weekday and subscribe to our daily newsletter: https://bloom.bg/3F3EJAK
Have questions or comments for Wes and the team? Reach us at bigtake@bloomberg.net.

The Winners and Losers of Trump’s Tax Policy
15:24

Trump’s Plan to Open the Strait of Hormuz? Close It
16:53

What Orbán’s Loss Means for Hungary, Russia and Trump
18:12